Clinical trials
Completed Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 11 |
| 2011 | 6 |
| 2012 | 11 |
| 2013 | 11 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 156 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kansai Hepatobiliary Oncology Group | 9 |
| AstraZeneca | 7 |
| National Cancer Institute (NCI) | 5 |
| Seoul National University Hospital | 5 |
| Massachusetts General Hospital | 4 |
| University of Michigan Rogel Cancer Center | 4 |
| ASLAN Pharmaceuticals | 3 |
| Asan Medical Center | 3 |
| National Health Research Institutes, Taiwan | 3 |
| Shanghai Zhongshan Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 156 |
| Pancreatic Neoplasms | 37 |
| Cholangiocarcinoma | 30 |
| Gallbladder Neoplasms | 21 |
| Colorectal Neoplasms | 13 |
| Liver Neoplasms | 13 |
| Neoplasms | 13 |
| Stomach Neoplasms | 12 |
| Bile Duct Neoplasms | 9 |
| Esophageal Neoplasms | 8 |
Trials
Showing 51 to 75 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.